• A hospital medication mix-up during knee surgery led to a devastating spinal injury claim
• Four patients reportedly received the wrong drug, and one says the fallout changed her life
• The lawsuit alleges severe nerve damage, paralysis, and a long road through rehab
• The case highlights drug labeling, verification, and patient safety breakdowns
• The hospital says it is reviewing the incident and cooperating with the legal process
A Tennessee woman is accusing a Nashville hospital of a catastrophic medication error during knee replacement surgery, saying the mistake left her unable to walk and changed the entire course of her life. The lawsuit seeks $150 million and centers on a claim that the wrong drug was injected into her spinal canal during the procedure.
According to the complaint, Linda Gilbert was 78 when she went in for surgery at Ascension Saint Thomas Midtown. Instead of receiving the anesthetic that was intended, she alleges potassium phosphate was used, a drug that is not meant for that kind of spinal injection.
The filing says the consequences were immediate and brutal. It claims the injection caused serious damage to her spinal cord and nerves, leaving her with incomplete paraplegia, profound weakness in both legs, and a loss of independence that included no longer being able to walk or drive.
Hospital records and a public statement previously acknowledged that four surgery patients received potassium phosphate instead of mepivacaine on Aug. 14. The lawsuit says Gilbert’s case was the worst of the group, and that earlier complaints from other patients should have sounded the alarm before things got even more serious.
Her complaint also says she suffered shock and respiratory failure and needed a ventilator. At the time the lawsuit was filed, it says she was still in inpatient rehabilitation at a spinal cord injury center in Atlanta, which gives a sense of just how severe the aftermath has been.
The lawsuit points to more than just one bad injection. It accuses staff of continuing to use syringes from the same batch after two patients reported burning pain, and it says there were failures in medication preparation, verification, and timely treatment. That kind of chain reaction is exactly what makes medical errors so hard to shake off once they start.
Potassium phosphate is normally used to treat low phosphorus levels and is given intravenously after being diluted. Its warning label says it can be dangerous if used improperly, with risks that include abnormal heart rhythms, cardiac arrest, seizures, and death.
Those warnings are tied to IV use, not a spinal injection, but the contrast only sharpens the alleged error. A drug with a narrow, specific purpose can become dangerous fast when it ends up in the wrong place, and the complaint argues that is exactly what happened here.
Gilbert is seeking $50 million in compensatory damages and another $100 million in punitive damages. That amount reflects more than physical harm alone, since the filing says the injuries are permanent and life-altering, with no easy path back to the life she had before surgery.
Ascension Saint Thomas has said it is aware of the complaint and is cooperating with the legal process, but has not offered much beyond that because the matter is ongoing. In earlier statements, the hospital said its focus remained on patient safety and that it was working with an independent quality consultant to review corrective actions and process changes.
The case lands against the backdrop of how common knee replacement surgery has become in the United States. With hundreds of thousands of procedures done each year, the expectation is not perfection, but it is basic that the right medication reaches the right patient in the right way.
That is where the human part of this story hits hardest. A routine operation is supposed to relieve pain and restore movement, not leave a patient fighting for mobility, breathing support, and the chance to live independently again.
